The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of neoadjuvant chemohormonal therapy (NAC) in prostate cancer (PC) with response assessment using PSMA PET/MRI.
 
Christos Kyriakopoulos
Consulting or Advisory Role - Exelixis
Speakers' Bureau - The France Foundation
Research Funding - Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Brian Johnson
Employment - Onexio Biosystems
Leadership - Onexio Biosystems
Stock and Other Ownership Interests - Onexio Biosystems
Patents, Royalties, Other Intellectual Property - Onexio Biosystems
 
Erika Heninger
No Relationships to Disclose
 
Tariq A. Khemees
No Relationships to Disclose
 
Alejandro Roldán-Alzate
No Relationships to Disclose
 
Wei Huang
Stock and Other Ownership Interests - PathomIQ
Research Funding - PathomIQ
Travel, Accommodations, Expenses - PathomIQ
 
David J. Beebe
Employment - Salus Discovery
Leadership - Lynx Biosciences; Onexio Biosystems; Salus Discovery
Stock and Other Ownership Interests - Bellbrook Labs; Lynx Biosciences; Onexio Biosystems; Salus Discovery; Stacks to the Future; Turba
Consulting or Advisory Role - Abbott Laboratories; Salus Discovery
Patents, Royalties, Other Intellectual Property - Onexio Biosystems; Salus Discovery; Stacks to the Future
Travel, Accommodations, Expenses - Abbott Laboratories; Lynx Biosciences; Onexio Biosystems; Salus Discovery
 
Hamid Emamekhoo
Consulting or Advisory Role - Bayer; Exelixis
Travel, Accommodations, Expenses - DAVA Pharmaceuticals
 
Shane A. Wells
No Relationships to Disclose
 
David Frazier Jarrard
No Relationships to Disclose
 
Steve Y. Cho
Research Funding - GE Healthcare
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - Immunomedics; Janssen; Sanofi; Sanofi
Research Funding - Agensys (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.